Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 24, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 17, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 15, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 13, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 8, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 7, 2017View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-139

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI) PKU, LEMS

Products

Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information